TrkB-mediated sustained neuroprotection is sex-specific and -dependent in adult mice following neonatal hypoxia ischemia

Vishal Chanana,Margaret Hackett,Nazli Deveci,Nur Aycan,Burak Ozaydin,Nur Sena Cagatay,Damla Hanalioglu,Douglas B. Kintner,Karson Corcoran,Sefer Yapici,Furkan Camci,Jens Eickhoff,Karyn M. Frick,Peter Ferrazzano,Jon E. Levine,Pelin Cengiz
DOI: https://doi.org/10.1186/s13293-023-00573-0
2024-01-05
Biology of Sex Differences
Abstract:Neonatal hypoxia ischemia (HI) related brain injury is one of the major causes of life-long neurological morbidities that result in learning and memory impairments. Evidence suggests that male neonates are more susceptible to the detrimental effects of HI, yet the mechanisms mediating these sex-specific responses to neural injury in neonates remain poorly understood. We previously tested the effects of treatment with a small molecule agonist of the tyrosine kinase B receptor (TrkB), 7,8-dihydroxyflavone (DHF) following neonatal HI and determined that females, but not males exhibit increased phosphorylation of TrkB and reduced apoptosis in their hippocampi. Moreover, these female-specific effects of the TrkB agonist were found to be dependent upon the expression of . These findings demonstrated that TrkB activation in the presence of comprises one pathway by which neuroprotection may be conferred in a female-specific manner. The goal of this study was to determine the role of -dependent TrkB-mediated neuroprotection in memory and anxiety in young adult mice exposed to HI during the neonatal period.
genetics & heredity,endocrinology & metabolism
What problem does this paper attempt to address?